Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Fennec Pharmaceuticals Inc is a clinical-stage biotechnology company. It is primarily engaged in research and development activities. The company is developing Sodium Thiosulfate (STS), a chemo-protectant against hearing loss associated with platinum-based chemotherapy. Its lead product candidate is... Fennec Pharmaceuticals Inc is a clinical-stage biotechnology company. It is primarily engaged in research and development activities. The company is developing Sodium Thiosulfate (STS), a chemo-protectant against hearing loss associated with platinum-based chemotherapy. Its lead product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin induced hearing loss, or ototoxicity in children. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.09 | 1.31004366812 | 6.87 | 7.06 | 6.58 | 49599 | 6.82466165 | CS |
| 4 | 0.31 | 4.66165413534 | 6.65 | 7.06 | 6.16 | 47520 | 6.72065142 | CS |
| 12 | 0.86 | 14.0983606557 | 6.1 | 7.06 | 5.47 | 60902 | 6.31566631 | CS |
| 26 | 1.67 | 31.5689981096 | 5.29 | 7.06 | 3.96 | 95147 | 5.46460895 | CS |
| 52 | -2.83 | -28.9070480082 | 9.79 | 11.49 | 3.96 | 111518 | 6.94063443 | CS |
| 156 | 2.12 | 43.8016528926 | 4.84 | 11.92 | 3.96 | 99700 | 7.89923459 | CS |
| 260 | -0.26 | -3.60110803324 | 7.22 | 11.92 | 3.8219 | 124325 | 7.48115977 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
